FYN and lupus nephritis: Regarding passive immunotherapeutic strategies such as ICI, FYN-activating signatures have been associated with lupus nephritis, an autoimmune condition (174), loosely suggesting that increased FYN activity might increase the risk of autoimmune complications following ICI.